Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Vietnam Dong: Stable despite widening trade deficit – Commerzbank

Vietnam Dong: Stable despite widening trade deficit – Commerzbank

FXStreetFXStreet2026/08/04 20:39

Commerzbank analysts note that Vietnam’s July inflation eased to 4.5% year-on-year, keeping the average near the 4.5% target, while the trade deficit widened to USD 3.6 billion on strong import growth driven by energy and capital goods. Despite external headwinds and future CBAM-related risks for steel exports, USD/VND has stayed stable around 26,277, with VND slightly stronger year-to-date.

Inflation moderates as imports surge

"On trade, the July trade deficit widened to USD3.6bn (Bloomberg consensus: USD2.5bn) vs USD2.6bn in June, marking the eighth consecutive monthly deficit."

"Looking ahead, steel exports are expected to face headwinds from the EU's Carbon Border Adjustment Mechanism (CBAM) and existing US anti-dumping measures on certain Vietnamese steel products."

"While the widening trade deficit bears watching, it largely reflects strong imports of capital goods, intermediate inputs and energy associated with expanding manufacturing capacity rather than weakening external competitiveness."

"FDI disbursements rose a further 11.8% yoy in the first seven months of 2026, suggesting investment momentum remains robust despite rising external headwinds."

"In FX, USD/VND rose 0.1% to 26,277 yesterday."

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma

GlaxoSmithKline announced on Tuesday that it has reached an agreement with Chinese biotechnology company ImmuneOnco to acquire the global rights to one of the latter’s trispecific T-cell engagers (TCE) for a total transaction amount of up to $750 million.

智通财经2026/09/15 08:06
GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma